PerkinElmer, Inc. (PKI): Price and Financial Metrics
PerkinElmer, Inc. (PKI)
Today's Latest Price: $84.32 USD
Updated Feb 27 12:00am
Add PKI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
PKI Stock Summary
- With a one year PEG ratio of 436.58, Perkinelmer Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.3% of US stocks.
- Perkinelmer Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.5% of US equities in our set.
- The price/operating cash flow metric for Perkinelmer Inc is higher than 89.48% of stocks in our set with a positive cash flow.
- Stocks with similar financial metrics, market capitalization, and price volatility to Perkinelmer Inc are CAE, ELAN, WAT, HOLX, and ITT.
- PKI's SEC filings can be seen here. And to visit Perkinelmer Inc's official web site, go to www.perkinelmer.com.
PKI Stock Price Chart More Charts
PKI Price/Volume Stats
| Current price | $84.32 | 52-week high | $103.00 |
| Prev. close | $86.00 | 52-week low | $78.35 |
| Day low | $83.63 | Volume | 1,015,100 |
| Day high | $87.72 | Avg. volume | 672,487 |
| 50-day MA | $96.24 | Dividend yield | 0.33% |
| 200-day MA | $90.25 | Market Cap | 9.37B |
PerkinElmer, Inc. (PKI) Company Bio
PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The company was founded in 1931 and is based in Waltham, Massachusetts.
PKI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $84.32 | $26.16 | -70% |
Below please find a table outlining a discounted cash flow forecast for PKI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Perkinelmer Inc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Perkinelmer Inc ended up being:
- 81% of the company's capital comes from equity, which is greater than 59.31% of stocks in our cash flow based forecasting set.
- The weighted average cost of capital for the company is 8. This value is greater than merely 18.73% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -70% |
| 1% | -70% |
| 2% | -70% |
| 3% | -69% |
| 4% | -69% |
| 5% | -69% |
DHR, EW, GKOS, ZBH, and NEO can be thought of as valuation peers to PKI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Top Stories View All
CGC SNDL IIPR GWPH TLRY Cannabis Stocks: The Week in Review
Best & Worst Performing Stock Industries for February 27, 2020
Best & Worst Performing Small Cap Stocks for February 27, 2020
Best & Worst Performing Mid Cap Stocks for February 27, 2020
Best & Worst Performing Large Cap Stocks for February 27, 2020
View All Top Stories
Loading social stream, please wait...